Biofrontera Inc. (BFRIW)Woburn, United States | NasdaqCM
0.03 USD
0.00
(-0.398%) ⇩
(Aug. 28, 2026, 3:40 p.m.
EDT)
|
Hot Take ↕ | Aug. 22, 2026, 3:28 a.m. EDT
The immediate outlook is severely bearish as the security trades at its 52-week low of $0.03, indicating a complete lack of upward momentum and a stale trading range that offers no near-term catalyst. While the company recently reported a significant 56.86% surge in EPS for Q1 2026, this isolated earnings beat cannot mask the deteriorating fundamentals: the business is burning cash with negative operating and free cash flows, posting a massive debt-to-equity ratio of 126%, and generating negative returns on both assets and equity. The balance sheet is fragile, with debt exceeding cash reserves, creating a precarious situation for a penny-stock warrant structure. Furthermore, there is no dividend income to offset the capital loss, and the lack of multi-year price history prevents any assessment of long-term structural quality, leaving the investment thesis reliant solely on a speculative turnaround that the current financial metrics strongly dispute. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 125.991 |
| Revenue per Share | 3.923 |
| Beta | 0.80 |
| Profit Margins | -13.79% |
| Website | https://www.biofrontera-us.com |
| Attribute | Value |
|---|---|
| Address1 | 660 Main Street |
| Address2 | 1st Floor |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.798 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.419 |
| City | Woburn |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.025 |
| Current Ratio | 1.18 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.027 |
| Day Low | 0.025 |
| Debt To Equity | 125.991 |
| Display Name | Biofrontera |
| Ebitda | -5,968,000 |
| Ebitda Margins | -0.12925 |
| Eps Trailing Twelve Months | -1.296 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.027 |
| Fifty Two Week High Change | -0.0020000003 |
| Fifty Two Week High Change Percent | -0.07407408 |
| Fifty Two Week Low | 0.025 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.025 - 0.027 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 11,838,815 |
| Free Cashflow | -7,597,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 84 |
| Fullday Change | -0.00009999983 |
| Fullday Change Percent | -0.3984057 |
| Fullday Price | 0.025 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.79253 |
| Gross Profits | 36,595,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-10-29 |
| Language | en-US |
| Long Business Summary | Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. |
| Long Name | Biofrontera Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_531568773 |
| Net Income To Common | -6,365,000 |
| Open | 0.0971 |
| Operating Cashflow | -7,927,000 |
| Operating Margins | -0.04366 |
| Phone | 781 245 1325 |
| Previous Close | 0.0251 |
| Price Hint | 4 |
| Price To Book | 0.059665874 |
| Profit Margins | -0.13785 |
| Quick Ratio | 0.999 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00009999983 |
| Regular Market Change Percent | -0.3984057 |
| Regular Market Day High | 0.027 |
| Regular Market Day Low | 0.025 |
| Regular Market Day Range | 0.025 - 0.027 |
| Regular Market Open | 0.0971 |
| Regular Market Previous Close | 0.0251 |
| Regular Market Price | 0.025 |
| Regular Market Time | 1,787,946,010 |
| Regular Market Volume | 5,294 |
| Return On Assets | -0.1745 |
| Return On Equity | -9.88354 |
| Revenue Growth | 0.329 |
| Revenue Per Share | 3.923 |
| Sand P52 Week Change | 0.20204377 |
| Sector | |
| Sector Key | |
| Short Name | Biofrontera Inc. Warrants |
| Source Interval | 15 |
| State | MA |
| Symbol | BFRIW |
| Total Cash | 4,667,000 |
| Total Cash Per Share | 0.314 |
| Total Debt | 7,504,000 |
| Total Revenue | 46,175,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.296 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 5,221 |
| Website | https://www.biofrontera-us.com |
| Zip | 1,801 |